Literature DB >> 27086805

Peripancreatic Tuberculous Lymphadenitis with Biliary Obstruction Diagnosed by Endoscopic Ultrasound-guided Fine-needle Aspiration Biopsy.

Reiko Yamada1, Hiroyuki Inoue, Naohiko Yoshizawa, Takashi Kitade, Shunsuke Tano, Takashi Sakuno, Tetsuro Harada, Misaki Nakamura, Masaki Katsurahara, Yasuhiko Hamada, Kyosuke Tanaka, Noriyuki Horiki, Yoshiyuki Takei.   

Abstract

A 57-year-old man with a history of tuberculosis (TB) was found to have a pancreatic head mass, accompanied by stenosis of the common bile duct. Due to the inherent difficulty in differentiating pancreatic carcinoma from an inflammatory mass, endoscopic ultrasound-guided fine-needle aspiration biopsy (EUS-FNAB) was thus performed. The pathological findings confirmed granuloma with caseous necrosis, and the results of the QuantiFERON TB2G test were positive. Accordingly, the patient was diagnosed with peripancreatic TB and thereafter was successfully treated with anti-TB therapy. Based on the findings of this case, we conclude that EUS-FNAB is a useful modality for the diagnosis of pancreatic TB.

Entities:  

Mesh:

Year:  2016        PMID: 27086805     DOI: 10.2169/internalmedicine.55.6123

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  3 in total

1.  Pancreatic Tuberculosis: A Puzzle for Physicians. A Rare Case and Review of Literature.

Authors:  Prashanth Ashok Kumar; Gursharan Singh; John Biku Joseph; S Swaminathan; L Venkatakrishnan
Journal:  J Clin Diagn Res       Date:  2016-11-01

2.  Peripancreatic lymph node tuberculosis diagnosed by endoscopic ultrasound.

Authors:  Renzo Pinto-Carta; Fernando Sierra-Arango; Mariana Vásquez-Roldan; Erika D Pérez-Riveros
Journal:  JGH Open       Date:  2021-02-19

Review 3.  Left-sided portal hypertension caused by peripancreatic lymph node tuberculosis misdiagnosed as pancreatic cancer: a case report and literature review.

Authors:  Dajun Yu; Xiaolan Li; Jianping Gong; Jinzheng Li; Fei Xie; Jiejun Hu
Journal:  BMC Gastroenterol       Date:  2020-08-18       Impact factor: 3.067

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.